These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34782464)

  • 1. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases.
    Choi JK; Yu CR; Bing SJ; Jittayasothorn Y; Mattapallil MJ; Kang M; Park SB; Lee HS; Dong L; Shi G; Caspi RR; Egwuagu CE
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis.
    Kang M; Choi JK; Jittayasothorn Y; Egwuagu CE
    Front Immunol; 2020; 11():1051. PubMed ID: 32547555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-27-containing exosomes secreted by innate B-1a cells suppress and ameliorate uveitis.
    Kang M; Yadav MK; Mbanefo EC; Yu CR; Egwuagu CE
    Front Immunol; 2023; 14():1071162. PubMed ID: 37334383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Regulatory B Cells in Experimental Autoimmune Uveitis.
    Choi JK; Egwuagu CE
    Methods Mol Biol; 2021; 2270():437-450. PubMed ID: 33479912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.
    Egwuagu CE; Yu CR
    Crit Rev Immunol; 2015; 35(1):49-57. PubMed ID: 25746047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 35 Regulatory B Cells.
    Choi JK; Egwuagu CE
    J Mol Biol; 2021 Jan; 433(1):166607. PubMed ID: 32755620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements.
    Yu CR; Choi JK; Uche AN; Egwuagu CE
    J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-35 induces regulatory B cells that suppress autoimmune disease.
    Wang RX; Yu CR; Dambuza IM; Mahdi RM; Dolinska MB; Sergeev YV; Wingfield PT; Kim SH; Egwuagu CE
    Nat Med; 2014 Jun; 20(6):633-41. PubMed ID: 24743305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of
    Kang M; Lee HS; Choi JK; Yu CR; Egwuagu CE
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.
    Egwuagu CE; Yu CR; Sun L; Wang R
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):587-93. PubMed ID: 26279360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.
    Dambuza IM; He C; Choi JK; Yu CR; Wang R; Mattapallil MJ; Wingfield PT; Caspi RR; Egwuagu CE
    Nat Commun; 2017 Sep; 8(1):719. PubMed ID: 28959012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of gut-originating regulatory B cells in neuroinflammatory diseases.
    Neziraj T; Siewert L; Pössnecker E; Pröbstel AK
    Eur J Immunol; 2023 Nov; 53(11):e2250033. PubMed ID: 37624875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-existing CD19-independent GL7(-) Breg cells are expanded during inflammation and in mice with lupus-like disease.
    Wang X; Wei Y; Xiao H; Liu X; Zhang Y; Han G; Chen G; Hou C; Zhang L; Ma N; Shen B; Li Y; Egwuagu CE; Wang R
    Mol Immunol; 2016 Mar; 71():54-63. PubMed ID: 26852110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
    Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA sequencing analysis reveals the heterogeneity of IL-10 producing regulatory B cells in lupus-prone mice.
    Daamen AR; Alajoleen RM; Grammer AC; Luo XM; Lipsky PE
    Front Immunol; 2023; 14():1282770. PubMed ID: 38155972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
    Oladipupo FO; Yu CR; Olumuyide E; Jittaysothorn Y; Choi JK; Egwuagu CE
    Sci Rep; 2020 Oct; 10(1):16188. PubMed ID: 33004854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APRIL Induces a Novel Subset of IgA
    Fehres CM; van Uden NO; Yeremenko NG; Fernandez L; Franco Salinas G; van Duivenvoorde LM; Huard B; Morel J; Spits H; Hahne M; Baeten DLP
    Front Immunol; 2019; 10():1368. PubMed ID: 31258536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive mechanisms of regulatory B cells in mice and humans.
    Matsumura Y; Watanabe R; Fujimoto M
    Int Immunol; 2023 Feb; 35(2):55-65. PubMed ID: 36153768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR9 mediated regulatory B10 cell amplification following sub-total body irradiation: Implications in attenuating EAE.
    Hong J; Fang J; Lan R; Tan Q; Tian Y; Zhang M; Okunieff P; Zhang L; Lin J; Han D
    Mol Immunol; 2017 Mar; 83():52-61. PubMed ID: 28110075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5.
    Radomir L; Kramer MP; Perpinial M; Schottlender N; Rabani S; David K; Wiener A; Lewinsky H; Becker-Herman S; Aharoni R; Milo R; Mauri C; Shachar I
    Nat Commun; 2021 Mar; 12(1):1893. PubMed ID: 33767202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.